Commissioner Office Restructuring Will Shift 12% Of Resources To Centers
Executive Summary
A recently announced plan to restructure FDA's Office of the Commissioner will reduce the size of that office by 12%, FDA Commissioner Jane Henney, MD, estimated at a Senate Agriculture/FDA Appropriations Subcommittee hearing April 27.